Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016)
- PMID: 30366804
- DOI: 10.1016/j.vaccine.2018.10.062
Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016)
Abstract
Efforts driving universal coverage have recently been strengthened through implementation of the Global Vaccine Action Plan (GVAP) where cost estimates for immunization support were developed totaling US$40 billion of donor assistance by 2020. In addition to resource mobilization, there has been an increasing focus on improving both vaccine access and delivery systems. We track donor assistance for immunization by funding objective and channel from 1990 to 2016, and illustrate projections through 2020 to inform progress of the GVAP. Using available data from development agencies supporting immunization, we categorize funding by vaccine and quantify support for systems strengthening. We split time into four periods including the post universal childhood immunization era (1990-1999) and Gavi's three funding phases between 2000 and 2015, during which annualized funding changes are estimated. Lastly, we perform a linear extrapolation through 2020 to predict the success of stipulated resource mobilization targets. Double counting was eliminated and results presented in real 2017 US dollars. Over the last 27 years, funding for immunization increased by 10.5% annually, with non-Gavi funding increasing by 7.1% and Gavi funding by 23.6% in the last 17 years. Gavi disbursements targeting vaccines and health system improvements increased uniformly at 15%, compared to 22.5% for vaccines and 11.7% for system strengthening from non-Gavi channels. Funding fluctuated for non-Gavi channels with disbursements declining before 2000 and during Gavi funding phase II, while Gavi disbursements continued to grow relative the previous phase. New and underused vaccines were prioritized by Gavi whereas non-Gavi channels focused on elimination efforts. Projected funding targets were estimated to be on track for Gavi contrary to non-Gavi support which was estimated to remain 40% below the stipulated target. Renewed assessments for funding requirements need to be undertaken, while strengthening existing resource efficiencies in order to achieve current global universal coverage targets.
Keywords: Development assistance for health; GVAP; Gavi; HSS; Universal coverage; Vaccine.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.Vaccine. 2020 Jan 16;38(3):588-596. doi: 10.1016/j.vaccine.2019.10.057. Epub 2019 Nov 1. Vaccine. 2020. PMID: 31679863
-
Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).Vaccine. 2013 Apr 8;31(15):1886-91. doi: 10.1016/j.vaccine.2013.02.024. Epub 2013 Feb 24. Vaccine. 2013. PMID: 23462529
-
Perspective and investments in health system strengthening of Gavi, the Vaccine Alliance: a content analysis of health system strengthening-specific funding.Int Health. 2016 Jul;8(4):246-52. doi: 10.1093/inthealth/ihv063. Epub 2015 Nov 26. Int Health. 2016. PMID: 26612851 Free PMC article.
-
Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020.Vaccine. 2013 Apr 18;31 Suppl 2:B137-48. doi: 10.1016/j.vaccine.2013.01.036. Vaccine. 2013. PMID: 23598475 Review.
-
Challenges to sustainable immunization systems in Gavi transitioning countries.Vaccine. 2018 Oct 29;36(45):6858-6866. doi: 10.1016/j.vaccine.2018.06.012. Epub 2018 Sep 27. Vaccine. 2018. PMID: 30268735 Free PMC article. Review.
Cited by
-
Recovery of Routine Immunisation: Mapping External Financing Opportunities for Reaching Zero-Dose Children.Vaccines (Basel). 2023 Jun 26;11(7):1159. doi: 10.3390/vaccines11071159. Vaccines (Basel). 2023. PMID: 37514975 Free PMC article.
-
Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.Drug Saf. 2020 Jun;43(6):583-593. doi: 10.1007/s40264-020-00925-4. Drug Saf. 2020. PMID: 32239447 Free PMC article.
-
The global vaccine action plan monitoring and evaluation/accountability framework: Perspective.Vaccine. 2020 Jul 14;38(33):5384-5386. doi: 10.1016/j.vaccine.2020.04.036. Epub 2020 May 4. Vaccine. 2020. PMID: 32381481 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical